ZIMRIXBY FDA approval date

The FDA approved ZIMRIXBY on 31 Jul 2026.

FDA approval date
31 Jul 2026

Drug identity has not yet been verified against registry records

Also recorded as RITUXIMAB-CDXX

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-07-31DayZIMRIXBYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761376", "applicant_as_listed_by_fda": "DR REDDYS LABS SA", "brand_names": ["ZIMRIXBY"], "active_ingredients": ["RITUXIMAB-CDXX"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260731", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026